Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma tetranectin and ovarian neoplasms.

C K Høgdall1, E V Høgdall, U Hørding

  • 1Department of Obstetrics & Gynecology, Rigshospitalet, University of Copenhagen, Denmark.

Gynecologic Oncology
|November 1, 1991
PubMed
Summary

Plasma tetranectin levels are reduced in most ovarian cancers, showing potential as a biomarker for early detection. This finding could aid in identifying ovarian tumors, especially in earlier stages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2022
Same author

The value of surgical staging in patients with apparent early stage epithelial ovarian carcinoma.

Gynecologic oncology·2019
Same author

Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.

BMC cancer·2018
Same author

Individual and work-unit measures of psychological demands and decision latitude and the use of antihypertensive medication.

International archives of occupational and environmental health·2014
Same author

Elevated fetal steroidogenic activity in autism.

Molecular psychiatry·2014
Same author

Neonatal levels of neurotrophic factors and risk of autism spectrum disorders.

Acta psychiatrica Scandinavica·2012

Area of Science:

  • Gynecologic Oncology
  • Biomarker Discovery
  • Clinical Chemistry

Background:

  • Ovarian cancer diagnosis remains a challenge, particularly in early stages.
  • Identifying reliable biomarkers is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the predictive value of plasma tetranectin as a biomarker for ovarian tumors.
  • To assess the correlation between plasma tetranectin levels and tumor stage.

Main Methods:

  • Plasma tetranectin levels were measured in control subjects and patients with benign or malignant ovarian tumors.
  • Statistical analysis was performed to determine correlations and diagnostic sensitivities/specificities.

Main Results:

  • A significant reduction in plasma tetranectin was observed in most malignant ovarian tumor types.

Related Experiment Videos

  • A significant correlation was found between tumor stage and plasma tetranectin levels.
  • Sensitivity for early-stage (Stage 1) ovarian cancer detection ranged from 52-71%.

    • Conclusions:

    • Plasma tetranectin shows potential as a biomarker for detecting ovarian cancer.
    • Its utility is particularly noted in identifying early-stage disease.
    • Further research may validate its role in ovarian cancer diagnostics.